Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Psittacosis confirmed in bird keeper
budgies
Psittacosis most commonly affects parrots, parakeets, budgerigars, cockatiels. (stock photo)

Public Health England advises on signs of infection

A case of psittacosis, which primarily affects birds, has been confirmed in a bird keeper from Bristol.

Public Health England (PHE) is making owners aware of signs to look out for in birds and themselves.

Each year between 25 and 50 cases of psittacosis are laboratory confirmed in England and Wales. It most commonly affects parrots, parakeets, budgerigars, cockatiels, pigeons and doves. Ducks and turkeys may be affected but the infection is seen less frequently in chickens.

Birds may carry the organism without showing signs of disease, or display mild to severe illness including sleepiness, shivering, weight loss, breathing problems and diarrhoea.

The disease can be passed from birds to humans through airborne particles from feather dust, dried faeces or respiratory secretions. It can also be transmitted through handling the plumage and tissues of infected birds.

At most risk of contracting the disease are bird keepers and fanciers or those whom are exposed to infected birds through their occupation - for example vets, pet shop workers, wildlife and zoo workers and poultry slaughter-house employees.

In humans, it causes flu-like symptoms including fever, headaches and muscle aches, but can result in severe pneumonia and other non-respiratory health issues. Signs typically appear after 10 days though they may be seen within four to 30 days after exposure.

“Members of the public who may have come into contact with birds need to be assured that severe illness as a result of infection from this bacteria is rare," said Mike Wade from PHE South West, in a statement published on South Gloucestershire Council's website.

"However, it is important that those individuals are aware of signs and symptoms and discuss any concerns they may have with their GP."

Residents living close to the recently diagnosed individual have been informed and advised of necessary actions to undertake by Bristol City Council.

Anyone with concerns about birds purchased between 28 May and 3 June have been advised to contact their vet for advice.

For more information on psittacosis visit: https://www.gov.uk/psittacosis

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
Wales licenses Bluetongue vaccines for voluntary use

The Welsh government has approved three Bluetongue vaccines for emergency use in Wales.

From 1 March an online general licence will become available for the vaccines' use. They will then be obtainable on prescription and can be sold by veterinary practices.

After appropriate guidance, livestock keepers will be permitted to administer the vaccines themselves. The vaccines must be prescribed by a veterinary surgeon and detailed vaccination records must be kept for five years.

The decision comes as Bluetongue virus (BTV-3) continues to spread across England. The three vaccines are already licensed for use in England.

Richard Irvine, CVO for Wales, said: "This decision to licence these vaccines was informed by our recent risk assessment indicating that Wales is now at high risk of experiencing an incursion of Bluetongue this year.

"Our primary aim is to keep Bluetongue out of Wales through biosecurity, vigilance and safe sourcing of livestock."